Skip to main content

Advertisement

Log in

Krüppel-like factor 4 prevents centrosome amplification following γ-irradiation-induced DNA damage

  • Original Paper
  • Published:
Oncogene Submit manuscript

Abstract

Centrosome duplication is a carefully controlled process in the cell cycle. Previous studies indicate that the tumor suppressor, p53, regulates centrosome duplication. Here, we present evidence for the involvement of the mammalian Krüppel-like transcription factor, KLF4, in preventing centrosome amplification following DNA damage caused by γ-irradiation. The colon cancer cell line HCT116, which contains wild-type p53 alleles (HCT116 p53+/+), displayed stable centrosome numbers following γ-irradiation. In contrast, HCT116 cells null for the p53 alleles (HCT116 p53−/−) exhibited centrosome amplification after irradiation. In the latter cell line, KLF4 was not activated following γ-irradiation due to the absence of p53. However, centrosome amplification could be suppressed in irradiated HCT116 p53−/− cells by conditional induction of exogenous KLF4. Conversely, in a HCT116 p53+/+ cell line stably transfected with small hairpin RNA (shRNA) designed to specifically inhibit KLF4, γ-irradiation induced centrosome amplification. In these cells, the inability of KLF4 to become activated in response to DNA damage was directly associated with an increase in cyclin E level and Cdk2 activity, both essential for regulating centrosome duplication. Cotransfection experiments showed that KLF4 overexpression suppressed the promoter activity of the cyclin E gene. The results of this study demonstrated that KLF4 is both necessary and sufficient in preventing centrosome amplification following γ-radiation-induced DNA damage and does so by transcriptionally suppressing cyclin E expression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

Abbreviations

BSA:

bovine serum albumin

Cdk2:

cyclin-dependent kinase 2

DPBS:

Dulbecco's phosphate-buffered saline

FBS:

fetal bovine serum

GKLF:

gut-enriched Krüppel-like factor

KLF4:

Krüppel-like factor 4

MEFs:

mouse embryonic fibroblasts

PBS:

phosphate-buffered saline

shRNA:

small hairpin RNA

References

  • Al-Romaih K, Bayani J, Vorobyova J, Karaskova J, Park PC, Zielenska M and Squire JA . (2003). Cancer Genet. Cytogenet., 144, 91–99.

  • Bennett RA, Izumi H and Fukasawa K . (2004). Oncogene, 23, 6823–6829.

  • Botz J, Zerfass-Thome K, Spitkovsky D, Delius H, Vogt B, Eilers M, Hatzigeorgiou A and Jansen-Durr P . (1996). Mol. Cell. Biol., 16, 3401–3409.

  • Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW and Vogelstein B . (1998). Science, 282, 1497–1501.

  • Bunz F, Fauth C, Speicher MR, Dutriaux A, Sedivy JM, Kinzler KW, Vogelstein B and Lengauer C . (2002). Cancer Res., 62, 1129–1133.

  • Carder P, Wyllie AH, Purdie CA, Morris RG, White S, Piris J and Bird CC . (1993). Oncogene, 8, 1397–1401.

  • Carroll PE, Okuda M, Horn HF, Biddinger P, Stambrook PJ, Gleich LL, Li YQ, Tarapore P and Fukasawa K . (1999). Oncogene, 18, 1935–1944.

  • Chen X, Johns DC, Geiman DE, Marban E, Dang DT, Hamlin G, Sun R and Yang VW . (2001). J. Biol. Chem., 276, 30423–30428.

  • Dang DT, Mahatan CS, Dang LH, Agboola IA and Yang VW . (2001). Oncogene, 20, 4884–4890.

  • Donehower LA, Godley LA, Aldaz CM, Pyle R, Shi YP, Pinkel D, Gray J, Bradley A, Medina D and Varmus HE . (1996). Prog. Clin. Biol. Res., 395, 1–11.

  • Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, Crum CP and Munger K . (2000). Proc. Natl. Acad. Sci. USA, 97, 10002–10007.

  • Ekholm SV, Zickert P, Reed SI and Zetterberg A . (2001). Mol. Cell. Biol., 21, 3256–3265.

  • el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B . (1993). Cell, 75, 817–825.

  • Fukasawa K, Choi T, Kuriyama R, Rulong S and Vande Woude GF . (1996). Science, 271, 1744–1747.

  • Fukasawa K, Wiener F, Vande Woude GF and Mai S . (1997). Oncogene, 15, 1295–1302.

  • Garrett-Sinha LA, Eberspaecher H, Seldin MF and de Crombrugghe B . (1996). J. Biol. Chem., 271, 31384–31390.

  • Geng Y, Eaton EN, Picon M, Roberts JM, Lundberg AS, Gifford A, Sardet C and Weinberg RA . (1996). Oncogene, 12, 1173–1180.

  • Ghadimi BM, Sackett DL, Difilippantonio MJ, Schrock E, Neumann T, Jauho A, Auer G and Ried T . (2000). Genes Chromosomes Cancer, 27, 183–190.

  • Harvey M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, Pantazis P, Giovanella BC, Tainsky MA, Bradley A and Donehower LA . (1993). Oncogene, 8, 2457–2467.

  • Hinchcliffe EH, Li C, Thompson EA, Maller JL and Sluder G . (1999). Science, 283, 851–854.

  • Hinchcliffe EH and Sluder G . (2001). Genes Dev., 15, 1167–1181.

  • Hinchcliffe EH and Sluder G . (2002). Oncogene, 21, 6154–6160.

  • Hollstein M, Sidransky D, Vogelstein B and Harris CC . (1991). Science, 253, 49–53.

  • Joshi HC, Palacios MJ, McNamara L and Cleveland DW . (1992). Nature, 356, 80–83.

  • Kawamura K, Izumi H, Ma Z, Ikeda R, Moriyama M, Tanaka T, Nojima T, Levin LS, Fujikawa-Yamamoto K, Suzuki K and Fukasawa K . (2004). Cancer Res., 64, 4800–4809.

  • Kellogg DR . (1989). Nature, 340, 99–100.

  • Kirschner MW and Mitchison T . (1986). Nature, 324, 621.

  • Kuo KK, Sato N, Mizumoto K, Maehara N, Yonemasu H, Ker CG, Sheen PC and Tanaka M . (2000). Hepatology, 31, 59–64.

  • Lee JM, Abrahamson JL, Kandel R, Donehower LA and Bernstein A . (1994). Oncogene, 9, 3731–3736.

  • Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C and Salisbury JL . (2002). Proc. Natl. Acad. Sci. USA, 99, 1978–1983.

  • Lingle WL, Lutz WH, Ingle JN, Maihle NJ and Salisbury JL . (1998). Proc. Natl. Acad. Sci. USA, 95, 2950–2955.

  • Lingle WL and Salisbury JL . (1999). Am. J. Pathol., 155, 1941–1951.

  • Mantel C, Braun SE, Reid S, Henegariu O, Liu L, Hangoc G and Broxmeyer HE . (1999). Blood, 93, 1390–1398.

  • Mayer F, Stoop H, Sen S, Bokemeyer C, Oosterhuis JW and Looijenga LH . (2003). Oncogene, 22, 3859–3866.

  • Mussman JG, Horn HF, Carroll PE, Okuda M, Tarapore P, Donehower LA and Fukasawa K . (2000). Oncogene, 19, 1635–1646.

  • Ohtani K, DeGregori J and Nevins JR . (1995). Proc. Natl. Acad. Sci. USA, 92, 12146–12150.

  • Ouyang X, Wang X, Xu K, Jin DY, Cheung AL, Tsao SW and Wong YC . (2001). Biochim. Biophys. Acta, 1541, 212–220.

  • Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P and Doxsey SJ . (1998). Cancer Res., 58, 3974–3985.

  • Pihan GA, Purohit A, Wallace J, Malhotra R, Liotta L and Doxsey SJ . (2001). Cancer Res., 61, 2212–2219.

  • Pihan GA, Wallace J, Zhou Y and Doxsey SJ . (2003). Cancer Res., 63, 1398–1404.

  • Sato N, Mizumoto K, Nakamura M, Maehara N, Minamishima YA, Nishio S, Nagai E and Tanaka M . (2001). Cancer Genet. Cytogenet., 126, 13–19.

  • Sato N, Mizumoto K, Nakamura M, Nakamura K, Kusumoto M, Niiyama H, Ogawa T and Tanaka M . (1999). Clin. Cancer Res., 5, 963–970.

  • Schatten H, Wiedemeier AM, Taylor M, Lubahn DB, Greenberg NM, Besch-Williford C, Rosenfeld CS, Day JK and Ripple M . (2000). Biol. Cell, 92, 331–340.

  • Shields JM, Christy RJ and Yang VW . (1996). J. Biol. Chem., 271, 20009–20017.

  • Shields JM and Yang VW . (1997). J. Biol. Chem., 272, 18504–18507.

  • Sluder G, Thompson EA, Miller FJ, Hayes J and Rieder CL . (1997). J. Cell Sci., 110 (Part 4), 421–429.

  • Tarapore P and Fukasawa K . (2002). Oncogene, 21, 6234–6240.

  • Tarapore P, Okuda M and Fukasawa K . (2002). Cell Cycle, 1, 75–81.

  • Tokuyama Y, Horn HF, Kawamura K, Tarapore P and Fukasawa K . (2001). J. Biol. Chem., 276, 21529–21537.

  • Vogelstein B, Lane D and Levine AJ . (2000). Nature, 408, 307–310.

  • Waldman T, Kinzler KW and Vogelstein B . (1995). Cancer Res., 55, 5187–5190.

  • Weaver Z, Montagna C, Xu X, Howard T, Gadina M, Brodie SG, Deng CX and Ried T . (2002). Oncogene, 21, 5097–5107.

  • Weber RG, Bridger JM, Benner A, Weisenberger D, Ehemann V, Reifenberger G and Lichter P . (1998). Cytogenet. Cell Genet., 83, 266–269.

  • Yoon HS, Chen X and Yang VW . (2003). J. Biol. Chem., 278, 2101–2105.

  • Yoon HS and Yang VW . (2004). J. Biol. Chem., 279, 5035–5041.

  • Zhang W, Geiman DE, Shields JM, Dang DT, Mahatan CS, Kaestner KH, Biggs JR, Kraft AS and Yang VW . (2000). J. Biol. Chem., 275, 18391–18398.

  • Zhang W, Shields JM, Sogawa K, Fujii-Kuriyama Y and Yang VW . (1998). J. Biol. Chem., 273, 17917–17925.

  • Zhao W, Hisamuddin IM, Nandan MO, Babbin BA, Lamb NE and Yang VW . (2004). Oncogene, 23, 395–402.

Download references

Acknowledgements

We thank Dr B Vogelstein for providing the HCT116 p53+/+ and HCT116 p53−/− cell line and Dr R Weinberg for providing the cyclin E luciferase reporter plasmid. This work was in part supported by grants from the National Institutes of Health (DK52230, DK64399, and CA84197). VWY is the recipient of a Georgia Cancer Coalition Distinguished Cancer Clinician Scientist award. WBD is a recipient of a Medical Scientist Training Program grant.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vincent W Yang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoon, H., Ghaleb, A., Nandan, M. et al. Krüppel-like factor 4 prevents centrosome amplification following γ-irradiation-induced DNA damage. Oncogene 24, 4017–4025 (2005). https://doi.org/10.1038/sj.onc.1208576

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208576

  • Springer Nature Limited

Keywords

This article is cited by

Navigation